血清肾上腺髓质素前体在急性中毒患者中的应用分析

周峰, 刘志祯, 蔡华忠, 等. 血清肾上腺髓质素前体在急性中毒患者中的应用分析[J]. 临床急诊杂志, 2018, 19(9): 634-637. doi: 10.13201/j.issn.1009-5918.2018.09.012
引用本文: 周峰, 刘志祯, 蔡华忠, 等. 血清肾上腺髓质素前体在急性中毒患者中的应用分析[J]. 临床急诊杂志, 2018, 19(9): 634-637. doi: 10.13201/j.issn.1009-5918.2018.09.012
ZHOU Feng, LIU Zhizhen, CAI Huazhong, et al. Analysis of the application of serum precursor adrenomedullin in acute intoxication[J]. J Clin Emerg, 2018, 19(9): 634-637. doi: 10.13201/j.issn.1009-5918.2018.09.012
Citation: ZHOU Feng, LIU Zhizhen, CAI Huazhong, et al. Analysis of the application of serum precursor adrenomedullin in acute intoxication[J]. J Clin Emerg, 2018, 19(9): 634-637. doi: 10.13201/j.issn.1009-5918.2018.09.012

血清肾上腺髓质素前体在急性中毒患者中的应用分析

详细信息
    通讯作者: 刘志祯,E-mail:zhouf404891231@126.com
  • 中图分类号: R595

Analysis of the application of serum precursor adrenomedullin in acute intoxication

More Information
  • 目的:探讨血清肾上腺髓质素前体(pro-ADM)对急性中毒患者病情评估的应用价值。方法:检测我院98例中毒患者(中毒组)和30例对照组的血清pro-ADM,并对中毒患者进行入院的APACHE Ⅱ评分。根据30 d预后情况将中毒组分为死亡组(18例)、存活组(80例),比较中毒组与对照组的血清pro-ADM,并比较死亡组与中毒组、对照组的血清pro-ADM及APACHE Ⅱ评分,将中毒患者血清pro-ADM及APACHE Ⅱ评分进行相关性分析。采用受试者工作曲线(ROC)进行血清pro-ADM及APACHE Ⅱ评分在中毒患者预后分析。结果:①死亡组患者的pro-ADM及APACHE Ⅱ评分明显高于存活组(P<0.01),血清pro-ADM与APACHE Ⅱ评分呈正相关(r=0.625,P<0.01);②pro-ADM的AUC为0.794,95%可信区间为0.687~0.902,APACHE Ⅱ评分AUC为0.725,95%可信区间0.598~0.852;③ROC曲线中,pro-ADM截断值为1.99,敏感度0.833,特异度0.725,APACHE Ⅱ评分截断值14.5,敏感度0.778,特异度0.487。结论:急性中毒患者血清pro-ADM水平升高,联合检测pro-ADM和APACHE Ⅱ评分对急性中毒患者预后有一定的应用价值。
  • 加载中
  • [1]

    张秀英, 罗自珍, 杨蓉佳.急性有机磷农药中毒患者血浆和肽素表达的临床意义[J].中国急救医学, 2017, 37 (6):536-538.

    [2]

    Onitsuka H, Imamura T, Yamaga J, et al.Angio-tensinⅡstimulates cardiac adrenomedullin production and causes accumulation of mature adrenomedullin independently of hemodynamic stress in vivo[J].Horm Metab Res, 2005, 37 (5):281-285.

    [3]

    Kato J, Tsuruda T, Kita T, et al.Adrenomedullin:a protective factor for blood vessels[J].Arterioscler Thromb Vasc Biol, 2005, 25 (12):2480-2487.

    [4]

    Von Haehling S, Filippatos G S, Papassotiriou J, et al.Mid regional pro-adrenomedullin as a novel predictor of mortality in patients with chronic heart failure[J].Eur J Heart Fail, 2010, 12 (5):484-491.

    [5]

    Watanabe K, Takayasu M, Noda A, et al.Adrenomedullin reduces ischemic brain injury after transient middle cerebral artery occlusion in rats[J].Acta Neurochir (Wien), 2001, 143 (11):1157-1161.

    [6]

    Miyamoto N, Tanaka R, Shimosawa T, et al.Protein kinase Adependent suppression of reactive oxygen species in transient focal ischemia in adrenomedullindeficient mice[J].J Cereb Blood Flow Metab, 2009, 29 (11):1769-1779.

    [7]

    Travaglino F, De Berardinis B, Magrini L, et al.Utility of Procalcitonin (PCT) and Mid regional pro-Adrenomedullin (MR-proADM) in risk stratification of critically ill febrile patients in Emergency Department (ED).A comparison with APACHEⅡscore[J].BMC Infectious Diseases, 2012, 12:184-184.

    [8]

    雷艳梅, 周潇, 马建国, 等.降钙素原联合肾上腺髓质素前体中段肽在脓毒症诊断中的应用[J].广东医学, 2017, 38 (9):1383-1385.

    [9]

    付源伟, 郑亚安.预测严重脓毒症及感染性休克预后的生物标记物研究进展[J].中国急救医学, 2016, 36 (3):219-223.

    [10]

    Lassus J, Gayat E, Mueller C, et al.Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure:the Multinational Observational Cohort on Acute Heart Failure (MOCA) study[J].Int J Cardiol, 2013, 168 (3):2186-2194.

    [11]

    Shah R V, Truong Q A, Gaggin H K, et al.Mid-regional pro-atrial natriuretic peptide and pro-adrenomedullin testing for the diagnostic and prognostic evaluation of patients with acute dyspnoea[J].Eur Heart J, 2012, 33 (17):2197-2205.

    [12]

    Maisel A, Mueller C, Nowak R M, et al.Midregion prohormone adrenomedullin and prognosis in patients presenting with acute dyspnea:results from the BACH (Biomarkers in Acute Heart Failure) trial[J].J Am Coll Cardiol, 2011, 58 (10):1057-1067.

    [13]

    Vigu B, Leblanc P E, Moati F, et al.Mid-regional pro-adrenomedullin (MRproADM), a marker of positive fluid balance in critically ill patients:results of the ENVOL study[J].Crit Care, 2016, 20 (1):363-363.

    [14]

    Schuetz P, Hausfater P, Amin D, et al.Biomarkers from distinct biological pathways improve early risk stratification in medical emergency patients:the multinational, prospective, observational TRIAGE study[J].Crit Care, 2015, 19:377-377.

    [15]

    Tolppanen H, Rivas-Lasarte M, Lassus J, et al.Adrenomedullin:a marker of impaired hemodynamics, organ dysfunction, and poor prognosis in cardiogenic shock[J].Ann Int Care, 2017, 7 (1):6-6.

  • 加载中
计量
  • 文章访问数:  78
  • PDF下载数:  28
  • 施引文献:  0
出版历程
收稿日期:  2018-05-22

目录